Dopamine hypothesis of schizophrenia: making sense of it all. (Q36946141)

17 August 2017

1 reference

title

Dopamine hypothesis of schizophrenia: making sense of it all. (English)

1 reference

17 August 2017

0 references

2

Anissa Abi-Dargham

1 reference

17 August 2017

Mitsuru Toda

1

1 reference

PubMed ID

17880866

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Current Psychiatry Reports

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

4

1 reference

17 August 2017

329-336

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-007-0041-7

17 August 2017

0 references

cites work

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Prediction of relapse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Working memory dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0041-7

Dopamine transporter change in drug-naı̈ve schizophrenia: an imaging study with 99mTc-TRODAT-1

21 January 2018

1 reference

12 December 2020

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

1 reference

12 December 2020

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

12 December 2020

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

12 December 2020

Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

1 reference

12 December 2020

Altered prefrontal dopaminergic function in chronic recreational ketamine users

1 reference

12 December 2020

The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum

1 reference

12 December 2020

Brain dopamine d1 receptors in twins discordant for schizophrenia

1 reference

12 December 2020

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study

1 reference

12 December 2020

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

12 December 2020

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography

1 reference

12 December 2020

Brain dopamine receptors in schizophrenia: PET problems

1 reference

12 December 2020

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender.

1 reference

12 December 2020

D(1) receptors in prefrontal cells and circuits

1 reference

12 December 2020

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

1 reference

12 December 2020

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

12 December 2020

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

1 reference

12 December 2020

Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1 reference

12 December 2020

In vivo measurement of the vesicular monoamine transporter in schizophrenia

1 reference

12 December 2020

Mesocortical dopaminergic function and human cognition

1 reference

12 December 2020

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

1 reference

12 December 2020

Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.

1 reference

12 December 2020

Multiple output channels in the basal ganglia

1 reference

12 December 2020

Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia

1 reference

12 December 2020

Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone

1 reference

12 December 2020

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

12 December 2020

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

1 reference

12 December 2020

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

12 December 2020

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.

1 reference

12 December 2020

GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.

1 reference

12 December 2020

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.

1 reference

12 December 2020

In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390.

1 reference

12 December 2020

Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.

1 reference

12 December 2020

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

1 reference

12 December 2020

Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)

1 reference

12 December 2020

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation

1 reference

12 December 2020

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Dopamine, the prefrontal cortex and schizophrenia

1 reference

12 December 2020

Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

1 reference

12 December 2020

Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.

1 reference

12 December 2020

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

1 reference

12 December 2020

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

12 December 2020

Imaging D2 receptor occupancy by endogenous dopamine in humans.

1 reference

12 December 2020

Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice.

1 reference

12 December 2020

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

[3H]nemonapride binding in human caudate and putamen.

1 reference

12 December 2020

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

12 December 2020

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

12 December 2020

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

12 December 2020

Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.

1 reference

12 December 2020

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations

1 reference

12 December 2020

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

1 reference

12 December 2020

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

1 reference

12 December 2020

The experimental reproduction of amphetamine psychosis

1 reference

12 December 2020

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

1 reference

12 December 2020

Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.

1 reference

12 December 2020

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

12 December 2020

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

1 reference

12 December 2020

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

1 reference

12 December 2020

The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs

1 reference

12 December 2020

Genes and the parsing of cognitive processes

1 reference

12 December 2020

PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia

1 reference

12 December 2020

Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

1 reference

12 December 2020

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

12 December 2020

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

1 reference

12 December 2020

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

12 December 2020

Prefrontal cortical projections to the striatum in macaque monkeys: evidence for an organization related to prefrontal networks

1 reference

12 December 2020

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

1 reference

12 December 2020

Pathophysiologically based treatment interventions in schizophrenia

1 reference

12 December 2020

10.1007/S11920-007-0041-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17880866